Endometrial Thinning after Ovarian Stimulation using Letrozole or Clomiphene Citrate: A Randomized Trial
Keywords:
Clomiphene citrate; letrozole; ovulation induction; endometrial thickness; consecutive cyclesAbstract
Objective: To compare endometrial thickness after three consecutive cycles of ovulation induction with clomiphene
citrate versus letrozole.
Methods: Eighty-four women with normal menstrual interval who attended the university infertility clinic from
June 2016 to March 2017 were eligible for the study. After the endometrial thickness of baseline cycle was recorded,
all participants were randomized into two groups of clomiphene citrate or letrozole treatment for three consecutive
cycles. Endometrial thickness and estradiol level were measured when at least one follicle reached 17 mm in diameter.
The differences in endometrial thickness relative to baseline of the two groups were compared.
Results: A total of 62 patients completed three cycles of ovarian stimulation. Both drugs resulted in significantly
thinner endometrium compared with the baseline cycle thickness. The mean endometrial thickness was significantly
decreased in the clomiphene citrate group compared with letrozole group (7.46 ± 1.71 vs 8.88 ± 2.34 mm, p = 0.029).
Estradiol level on the day of induced ovulation was significantly higher in the clomiphene citrate group than in
the letrozole group (706.0 (207.9, 2209.0) vs 168.7 (30.0, 401.8), p < 0.001). The number of the follicles reaching 17 mm
on the day of induced ovulation was higher in the clomiphene citrate group (1.9 ± 0.8 vs 1.4 ± 0.5, p = 0.002).
Conclusion: Letrozole had less effect on endometrium thinning after three consecutive cycles of induced ovulation
compared with clomiphene citrate.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.